First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
How can CGRP therapies improve outcomes in workers’ compensation migraine claims?Migraines affect around one
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dig into part one of our
Enlyte is proud to return as an Elite Sponsor at the 2025 Workers' Compensation Institute (WCI) Conference in Orlando, Florida—th
The Growing Surge in Specialty Service CostsAs specialty services become a major driver of rising expenses, effective management of medica
The Hidden Costs of Administrative ComplexityManaging specialty services claims is a balancing act.